(SLM) SLM - NASDAQ
Sector: Financial Services | Industry: Credit Services | Exchange: NASDAQ (USA) | Market Cap: 4.134m USD | Total Return: -25% in 12m
Avg Turnover: 49.3M
EPS Trend: 65.2%
Qual. Beats: 2
Rev. Trend: 78.8%
Qual. Beats: 3
Warnings
Fakeout
Tailwinds
No distinct edge detected
SLM Corporation, widely known as Sallie Mae, operates as a specialized financial services institution focused on the United States education market. The company primarily generates revenue through the origination and servicing of private student loans intended to cover tuition and related educational expenses. To fund its lending operations, the firm maintains a banking subsidiary that offers consumer deposit products, including high-yield savings accounts and certificates of deposit.
As a major participant in the consumer finance sector, SLM operates within a highly regulated environment where credit quality is closely tied to national employment trends and higher education enrollment rates. Unlike federal loans, private education loans are credit-based and typically require a co-signer, which serves as a primary risk mitigation strategy for the business model. Investors may find additional data points on these valuation metrics through ValueRay.
Founded in 1972 and headquartered in Newark, Delaware, the company transitioned from a government-sponsored enterprise to a fully private entity. This evolution included a 2013 corporate restructuring that established its current focus on private credit following the spin-off of its government loan servicing business.
- Private student loan origination volume drives interest income and portfolio growth
- Federal interest rate pivots impact net interest margin and funding costs
- Credit quality and borrower default rates dictate provision for loan losses
- Legislative changes to federal student loan programs shift private market demand
- Strategic asset sales and share buybacks influence earnings per share performance
| Net Income: 748.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 3.58 > 1.0 |
| NWC/Revenue: -474.0% < 20% (prev -484.7%; Δ 10.63% < -1%) |
| CFO/TA 0.02 > 3% & CFO 645.6m > Net Income 748.3m |
| Net Debt (422.0m) to EBITDA (1.01b): 0.42 < 3 |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (197.9m) vs 12m ago -7.96% < -2% |
| Gross Margin: 54.04% > 18% (prev 48.12%; Δ 5.93% > 0.5%) |
| Asset Turnover: 10.57% > 50% (prev 10.42%; Δ 0.15% > 0%) |
| Interest Coverage Ratio: 1.08 > 6 (EBIT TTM 989.8m / Interest Expense TTM 918.3m) |
| A: -0.50 (Total Current Assets 6.95b - Total Current Liabilities 21.6b) / Total Assets 29.4b |
| B: 0.17 (Retained Earnings 5.01b / Total Assets 29.4b) |
| C: 0.03 (EBIT TTM 989.8m / Avg Total Assets 29.2b) |
| D: 0.09 (Book Value of Equity 2.44b / Total Liabilities 27.0b) |
| Altman-Z'' = -2.38 = D |
| DSRI: 0.96 (Receivables 1.53b/1.55b, Revenue 3.08b/3.01b) |
| GMI: 0.89 (GM 48.12% / 54.04%) |
| AQI: 0.94 (AQ_t 0.76 / AQ_t-1 0.81) |
| SGI: 1.02 (Revenue 3.08b / 3.01b) |
| TATA: 0.00 (NI 748.3m - CFO 645.6m) / TA 29.4b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of June 19, 2026, the stock is trading at USD 22.95 with a total of 2,879,569 shares traded.
Over the past week, the price has changed by +7.75%,
over one month by +5.67%,
over three months by +16.38% and
over the past year by -24.96%.
SLM has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy SLM.
- StrongBuy: 6
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 28.8 | 25.6% |
P/E Trailing = 6.0889
P/E Forward = 6.9061
P/S = 2.4822
P/B = 1.8911
P/EG = 0.5827
Revenue TTM = 3.08b USD
EBIT TTM = 989.8m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 5.67b USD (from longTermDebt, last quarter)
Short Term Debt = 498.9m USD (from shortTermDebt, last quarter)
Debt = 6.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 422.0m USD (calculated: Debt 6.17b - CCE 5.75b)
Enterprise Value = 4.56b USD (4.13b + Debt 6.17b - CCE 5.75b)
Interest Coverage Ratio = 1.08 (Ebit TTM 989.8m / Interest Expense TTM 918.3m)
EV/FCF = 7.06x (Enterprise Value 4.56b / FCF TTM 645.6m)
FCF Yield = 14.17% (FCF TTM 645.6m / Enterprise Value 4.56b)
FCF Margin = 20.95% (FCF TTM 645.6m / Revenue TTM 3.08b)
Net Margin = 24.28% (Net Income TTM 748.3m / Revenue TTM 3.08b)
Gross Margin = 54.04% ((Revenue TTM 3.08b - Cost of Revenue TTM 1.42b) / Revenue TTM)
Gross Margin QoQ = 68.53% (prev 64.44%)
Tobins Q-Ratio = 0.15 (Enterprise Value 4.56b / Total Assets 29.4b)
Interest Expense / Debt = 14.89% (Interest Expense 918.3m / Debt 6.17b)
Taxrate = 24.40% (241.5m / 989.8m)
NOPAT = 748.3m (EBIT 989.8m * (1 - 24.40%))
Current Ratio = 0.32 (Total Current Assets 6.95b / Total Current Liabilities 21.6b)
Debt / Equity = 2.53 (Debt 6.17b / totalStockholderEquity, last quarter 2.44b)
Debt / EBITDA = 0.42 (Net Debt 422.0m / EBITDA 1.01b)
Debt / FCF = 0.65 (Net Debt 422.0m / FCF TTM 645.6m)
Total Stockholder Equity = 2.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.57% (Net Income 748.3m / Total Assets 29.4b)
RoE = 31.16% (Net Income TTM 748.3m / Total Stockholder Equity 2.40b)
RoCE = 12.26% (EBIT 989.8m / Capital Employed (Equity 2.40b + L.T.Debt 5.67b))
RoIC = 2.56% (NOPAT 748.3m / Invested Capital 29.3b)
WACC = 10.52% (E(4.13b)/V(10.3b) * Re(9.43%) + D(6.17b)/V(10.3b) * Rd(14.89%) * (1-Tc(0.24)))
Discount Rate = 9.43% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.67 | Cagr: -5.84%
[DCF] Terminal Value 68.22% ; FCFF base≈645.6m ; Y1≈648.3m ; Y5≈686.7m
[DCF] Fair Price = 39.12 (EV 7.80b - Net Debt 422.0m = Equity 7.38b / Shares 188.6m; r=10.52% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 65.22 | EPS CAGR: 25.53% | SUE: 1.43 | # QB: 2
Revenue Correlation: 78.79 | Revenue CAGR: 5.22% | SUE: 0.89 | # QB: 3
EPS current Quarter (2026-06-30): EPS=0.47 | Chg30d=-4.11% | Revisions=-33% | Analysts=11
EPS next Quarter (2026-09-30): EPS=0.38 | Chg30d=-1.40% | Revisions=-33% | Analysts=11
EPS current Year (2026-12-31): EPS=3.15 | Chg30d=+0.00% | Revisions=+69% | GrowthEPS=-9.0% | GrowthRev=-2.8%
EPS next Year (2027-12-31): EPS=3.39 | Chg30d=+0.27% | Revisions=+54% | GrowthEPS=+7.7% | GrowthRev=+2.3%
[Analyst] Revisions Ratio: +69%